UK markets close in 5 minutes

Zymeworks Inc. (ZYME)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
5.96-0.16 (-2.61%)
As of 11:25AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
31,623
26,680
38,951
29,544
53,019
Operating expenses
Research development
223,290
199,752
168,534
115,900
56,684
Selling general and administrative
48,694
42,600
57,885
64,177
29,457
Total operating expenses
271,984
242,352
226,419
180,077
86,146
Operating income or loss
-240,361
-215,672
-187,468
-150,533
-33,127
Interest expense
-
-
-
-
166
Total other income/expenses net
1,283
1,309
1,648
-1,508
-3,730
Income before tax
-237,665
-212,359
-180,123
-146,019
-34,385
Income tax expense
-690
-516
429
-582
2,171
Income from continuing operations
-236,975
-211,843
-180,552
-145,437
-36,556
Net income
-236,975
-211,843
-180,552
-145,437
-36,556
Net income available to common shareholders
-236,975
-211,843
-180,552
-145,437
-36,556
Basic EPS
-
-4.11
-3.58
-3.83
-1.26
Diluted EPS
-
-4.61
-3.58
-3.83
-1.26
Basic average shares
-
51,554
50,382
38,022
29,090
Diluted average shares
-
52,132
50,382
38,022
29,090
EBITDA
-
-206,089
-177,189
-143,202
-30,589